Research Articles

Soft Tissue Sarcoma

A phase II study of tumor ablation in patients with metastatic sarcoma stable on chemotherapy

A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US

A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC).

A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers

Adjuvant Therapy Does Not Improve Survival for Early Stage Uterine Leiomyosarcoma

Cancer ‘vaccine’ eliminates tumors in mice

Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: The EORTC 62961-ESHO 95 randomized clinical trial

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

External beam radiation therapy for resectable soft tissue sarcoma: A systematic review and meta-analysis

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas

Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas

Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma

Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomas

Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates

Molecular studies of human carcinomas and sarcomas

Next-generation sequencing for patients with sarcoma: A single center experience

Nivolumab With Ipilimumab Promising for Pretreated Metastatic Sarcoma

Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study)

Options for Adjuvant Therapy for Uterine Leiomyosarcoma

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Renal Function Preservation in Surgical Resection of Primary Inferior Vena Cava Leiomyosarcoma Involving the Renal Veins:

Sarcoma management is slowly evolving

Salvage therapy in advanced adult soft tissue sarcoma: A systematic review and meta-analysis of randomized trials

Soft Tissue and Uterine Leiomyosarcoma

Systemic treatment in adult uterine sarcomas

T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.

The activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine

Use of PD-1 targeting, macrophage infiltration, and IDO pathway activation in sarcomas: A phase 2 clinical trial

Leiomyosarcoma Articles by Dr. Alexander Lazar:

Dr. Alexander Lazar (medical advisory council member) is a research pathologist from MD Anderson Cancer Center in Houston, Texas.

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma

Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas

Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value